Last, although the results of our study provide evidence for the MTHFR C677T polymorphism in the MTHFR gene as a potential biomarker for use in BC subtype analysis, a prospective study in a larger cohort of ethnically diverse patients is warranted to validate these findings. This evidence concerns the gene MTHFR and breast cancer.